Crossmark

Analysis of inflammation parameter value lymphocyte monocyte ratio (LMR), platelet lymphocyte ratio (PLR), and systemic inflammation response index (SIRI) to differentiate malignant and benign ovarian tumors

Crossref DOI link: https://doi.org/10.1186/s13104-025-07330-z

Published Online: 2025-07-28

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Salima, Siti

Sampeliling, Dave Grant

Permadi, Wiryawan

Sasotya, R. M. Sonny

Aziz, M. Alamsyah

Kurniadi, Andi

Nisa, Aisyah Shofiatun
License Information

Text and Data Mining valid from 2025-07-28

Version of Record valid from 2025-07-28
More Information

Article History

Received: 14 February 2025

Accepted: 13 June 2025

First Online: 28 July 2025

Declarations

:

: This study has been performed in accordance with the principles of the Declaration of Helsinki. It was reviewed and approved by the Research Ethics Committee of Dr. Hasan Sadikin General Hospital, Bandung (Ethical Approval No. LB.02.01/X.6.5/425/2023). Written informed consent was obtained from all participants or their legal guardians, as applicable. For retrospective data, a waiver of consent was granted by the ethics committee.

: Not applicable.

: The authors declare no competing interests.

: The author(s) report no conflicts of interest in this work.

Document is current

Any future updates will be listed below